Sanofi India, a Rs. 1,700 crore MNC, has suffered a setback during the third quarter ended September 2014 due to reduction of prices of some of the medicines. Its net profit declined by 19.4 per cent to Rs. 62 crore from Rs. 76.9 crore in the corresponding period of last year. Its net sales improved marginally by 3.1 per cent to Rs. 487 crore from Rs. 473 crore. With lower profit its EPS declined to Rs. 26.93 as against Rs. 33.43 in the last period. The Board of Directors declared interim dividend of 100 per cent for the year ended December 2014.

For the first half ended September 2014, Sanofi's net sales improved by 11.9 per cent to Rs. 1,394 crore from Rs. 1,245 crore and its net profit declined by 0.8 per cent to Rs. 171.2 crore from Rs. 172.6 crore.  

Meanwhile, Sanofi has sold its commercial premises, being five floors and corresponding car-parking spaces in the building known as Hoechst House situated at Nariman Point, Mumbai to Bright Star Investments Private Ltd and its Group companies for a total consideration of  Rs. 134.26 crore. Each floor admeasures 7442 sq. feet carpet area. The transaction is expected to be completed in the quarter ending December 31, 2014.